Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IMPDH2 | P12268 | 1/20 | 0.31 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21931806 | 0.88 | IMPDH2 (0.31) | IMPDH2LMNAHTTRAB9A | |
| SCHEMBL21929248 | 0.85 | TNKS (0.37) | — | |
| SCHEMBL23097989 | 0.84 | LRRK2 (0.36) | LRRK2 | |
| SCHEMBL21928473 | 0.83 | KDM4E (0.36) | — | |
| SCHEMBL21928475 | 0.82 | GABRA1 (0.37) | IMPDH2HTT | |
| SCHEMBL21931809 | 0.82 | KDM4E (0.35) | — | |
| SCHEMBL21929095 | 0.82 | DUSP3 (0.32) | — | |
| SCHEMBL21928474 | 0.82 | ALKBH5 (0.34) | IMPDH2LMNA | |
| SCHEMBL21931808 | 0.82 | RAB9A (0.32) | RAB9A | |
| SCHEMBL21929098 | 0.81 | LMNA (0.31) | IMPDH2LMNAHTTRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220388960-A1 | ORGANIC MOLECULES FOR USE IN LIGHT-EMITTING DEVICES | CYNORA GMBH (DE) | 2022-12-08 | — | — | US | disclosed |
| EP-3609978-B1 | ORGANIC MOLECULES IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2021-03-17 | — | — | EP | disclosed |
| US-20200136054-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-04-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200136054-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | OR10J3, OGFR, OR51E2 | IMPDH2 3712/4885LRRK2 852/4885LMNA 4592/4885 |
| US-20220388960-A1 | ORGANIC MOLECULES FOR USE IN LIGHT-EMITTING DEVICES | ALDH1A2, AOX1, CYBA | IMPDH2 1049/4885LRRK2 1976/4885LMNA 2772/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.